Concepts of hemopoietic cell amplification. Synergy, redundancy and pleiotropy of cytokines affecting the regulation of erythropoiesis.

Hemopoietic cell amplification in vivo is regulated by various mechanisms which appear to be under control of many hemopoietic growth factors. Quiescent stem cells can be activated into cell cycle, dividing progenitor cells can reduce their cycle time, the differentiation velocity (i.e. transit-time) can be manipulated, apoptosis can be prevented, and finally, at least in the murine system, migration of cells between the microenvironments in marrow and spleen may take place. Perturbations of any of the parameters by which these mechanisms are defined, will affect in vivo blood cell production. In this review the consequences of these perturbations, and the role of growth factors herein, are discussed. These fundamental aspects of the regulation of hemopoiesis are illustrated with recent data showing the synergistic, redundant and pleiotropic effects of SCF, IL-11, EPO and G-CSF on the in vivo formation of erythrocytes. Given the overwhelming number of growth factor-related studies that are now appearing, a re-evaluation of data, available in the literature, in the context of the mechanistic approach of growth factor-dependent hemopoiesis which is presented in this paper, seems to be useful and warranted.

[1]  M. Koury,et al.  Programmed cell death (apoptosis) in hematopoiesis. , 1992, Experimental hematology.

[2]  N. Mahmud,et al.  Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. , 1995, Blood.

[3]  S. Korsmeyer,et al.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.

[4]  T. Dexter,et al.  Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. , 1994, Blood.

[5]  D. Williams,et al.  Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. , 1988, Experimental hematology.

[6]  H E Wichmann,et al.  A mathematical model of erythropoiesis in mice and rats Part 2: Stimulated erythropoiesis , 1989, Cell and tissue kinetics.

[7]  A Howell,et al.  The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Benjamin,et al.  Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. , 1994, Experimental hematology.

[9]  D. Bodine.  Mobilization of peripheral blood 'stem' cells: where there is smoke, is there fire? , 1995, Experimental Hematology.

[10]  M. Baert,et al.  Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. , 1991, Blood.

[11]  M. Loeffler,et al.  Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia. , 1992, Experimental hematology.

[12]  G. Zant.  Studies of hematopoietic stem cells spared by 5-fluorouracil. , 1984 .

[13]  Thea D. Tlsty,et al.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.

[14]  R. Neta,et al.  Interleukin 1 is a radioprotector. , 1986, Journal of immunology.

[15]  M. Loeffler,et al.  Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy. , 1995, Cancer research.

[16]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[17]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[18]  A. Wickrema,et al.  Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. , 1994, The Journal of clinical investigation.

[19]  M. Ogawa,et al.  Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.

[20]  W. Nijhof,et al.  Cell Kinetic Behaviour of A Synchronized Population of Erythroid Precursor Cells in vitro , 1984, Cell and tissue kinetics.

[21]  K. Zsebo,et al.  Radioprotection of mice by recombinant rat stem cell factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Dexter,et al.  Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis , 1988, Nature.

[23]  M. Loeffler,et al.  In vivo effects of interleukin‐11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis , 1995, British journal of haematology.

[24]  M. Loeffler,et al.  Hematotoxic effects of benzene analyzed by mathematical modeling. , 1992, Toxicology.

[25]  T. M. Dexter,et al.  Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors , 1993, Cell.

[26]  D. Harrison,et al.  5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. , 1990, Experimental hematology.

[27]  M. Collins,et al.  Regulation of apoptosis in interleukin‐3‐dependent hemopoietic cells by interleukin‐3 and calcium ionophores. , 1990, The EMBO journal.

[28]  D. Williams,et al.  Interleukin-1 alpha enhances the in vitro survival of purified murine granulocyte-macrophage progenitor cells in the absence of colony-stimulating factors. , 1988, Blood.

[29]  D. Metcalf,et al.  Effects of GM‐CSF deprivation on precursors of granulocytes and macrophages , 1982, Journal of cellular physiology.

[30]  T. Dexter,et al.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.

[31]  V. Quesniaux,et al.  Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. , 1992, Blood.

[32]  M. Ogawa,et al.  Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. , 1992, Blood.

[33]  R. Frenck,et al.  Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Koury,et al.  Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.

[35]  M. Ogawa,et al.  Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Loeffler,et al.  Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment. , 1993, Experimental Hematology.

[37]  T. Dexter,et al.  Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. , 1986, Differentiation; research in biological diversity.

[38]  M. Loeffler,et al.  The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor. , 1995, Blood.

[39]  J. Lotem,et al.  Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. , 1992, Blood.

[40]  G. Hodgson,et al.  Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? , 1979, Nature.

[41]  J. Lotem,et al.  Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. , 1993, Blood.

[42]  M. Loeffler,et al.  Effects of continuous stem cell factor administration on normal and erythropoietin‐stimulated murine hemopoiesis: Experimental results and model analysis , 1995, Stem cells.

[43]  B. Dontje,et al.  Mechanistic options of erythropoietin-stimulated erythropoiesis. , 1995, Experimental hematology.

[44]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[45]  H E Wichmann,et al.  A mathematical model of erythropoiesis in mice and rats Part 1: Structure of the model , 1989, Cell and tissue kinetics.

[46]  M. Loeffler,et al.  A mathematical model of erythropoiesis suggests an altered plasma volume control as cause for anemia in aged mice , 1990, Experimental Gerontology.

[47]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[48]  T. Dexter,et al.  Effect of haematopoietic cell growth factor on intracellular ATP levels , 1983, Nature.

[49]  D. Metcalf.  Clonal analysis of proliferation and differentiation of paired daughter cells: action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Dexter,et al.  Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. , 1991, Blood.

[51]  K. Muta,et al.  Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. , 1995, Blood.

[52]  M. Loeffler,et al.  Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: in vivo interactions and dose-response surfaces. , 1994, Blood.

[53]  H E Wichmann,et al.  A mathematical model of erythropoiesis in mice and rats. Part 4: Differences between bone marrow and spleen , 1990, Cell and tissue kinetics.

[54]  J. Down,et al.  Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. , 1993, Experimental hematology.

[55]  D. Harrison,et al.  Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. , 1991, Blood.

[56]  B. Lord,et al.  Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin‐3 and granulocyte/macrophage colony‐stimulating factor in combination , 1994, International journal of cancer.